Plenarsitzungen/Joint Sessions
You can look forward to an exciting and varied plenary programme. You can expect top-class experts as well as interesting contributions from the cooperating professional societies.
| 11:00–12:20 Chairs | News and updates from the sections of the DGNC Roland H. Goldbrunner (Cologne), Veit Rohde (Göttingen) | |
| 11:00 | News and updates from the Section Neurotrauma and Intensive Care Medicine | |
| 11:10 | News and updates from the Section Functional Neurosurgery | |
| 11:20 | News and updates from the Section Spine | |
| 11:30 | News and updates from the Section Peripheral Nerves | |
| 11:40 | News and updates from the Section Neurooncology | |
| 11:50 | News and updates from the Section Paediatric Neurosurgery | |
| 12:00 | News and updates from the Section Vascular Neurosurgery | |
| 12:10 | News and updates from the Section Technology and Innovation | |
| 16:00–17:30 Chairs | New horizons in Functional Neurosurgery Joint session with the European Society for Stereotactic and Functional Neurosurgery (ESSFN) Veerle Visser-Vandewalle (Cologne), Joachim K. Krauss (Hannover) | |
| 16:00 | Awake versus asleep DBS in Parkinson’s disease | |
| 16:30 | DBS in Alzheimer´s Disease | |
| 17:00 | Restoring movement after spinal cord injury – the promise of neurotechnology Jocelyne Bloch (Lausanne/CH) | |
| 10:45–12:15 Chairs | Meningioma management Joint session with the Society for Neuro-Oncology (SNO) and European Association of Neuro-Oncology (EANO) Gelareh Zadeh (Toronto/CA), Roland H. Goldbrunner (Cologne) | |
| 10:45 | EANO guidelines on management of meningiomas | |
| 11:00 | Skull base meningiomas | |
| 11:15 | Basic science on meningiomas | |
| 11:30 | Future of meningioma therapy | |
| 16:30–17:30 Chairs | Changing paradigms for Brain Metastases Joint session with the European Society for Medical Oncology (ESMO) Emilie Le Rhun (Zürich/CH), Maximilian Ruge (Cologne) | |
| 16:30 | EANO-ESMO guidelines on brain metastases | |
| 16:42 | Surgical aspects | |
| 16:54 | Radiotherapy for brain metastases – from global to focal therapy | |
| 17:06 | Systemic therapy of brain metastases across the blood brain barrier | |
| 17:18 | Outlook Stefan Grau (Fulda) | |
| 09:30–10:30 Chairs | Developments in neurovascular surgery Daniel Hänggi (Düsseldorf), Konstantions Fountas (Larissa/GR) | |
| 09:30 | News on the management of patients with cavernomas | |
| 09:45 | EMMA study | |
| 10:00 | Minimally invasive ICB treatment. Renaissance of surgery? | |
| 10:15 | Endovascular treatment of recanalised aneurysms initially treated by endovascular approach | |
| 12:00–13:30 Chairs | Glioblastom therapy. Quo vadis? Joint Session with the Neuro-oncological Working Group (NOA) Stephanie Combs (Munich), Walter Stummer (Münster) | |
| 12:00 | Molecular genetics of glioblastoma – recent advances and diagnostic implications | |
| 12:15 | New concepts for intraoperative visualisation | |
| 12:30 | Radiation oncology | |
| 12:45 | Immunotherapy and targeted therapies | |
| 12:00–13:30 Chairs | Maximal versus minimal in spine fusion Joint Session with the German Spine Society (DWG) Alexandros Brotis (Larissa/GR), Peter Vajkoczy (Berlin) | |
| 12:00 | Pros and Cons of different fusion techniques | |
| 12:15 | Management of pathological fractures | |
| 12:30 | Update on modern fusion surgery | |
| 12:45 | Cervical fusions | |
| 13:00 | Special cases | |